Clinical Trials Logo

Clinical Trial Summary

A chronic total occlusion (CTO) is present in 15-20% of patients who are referred for invasive coronary angiography. CTO Percutaneous Coronary Intervention (PCI) procedure success rates have increased over the years and can be as high as 90% when performed by high-volume CTO operators.Procedurally, excess calcification in the CTO anatomy is one factor which makes it difficult to complete the procedure or obtain ideal stent expansion. Excess calcification is best identified by Computed Tomography Coronary Angiography (CTCA) rather than invasive angiography. The investigators plan to retrospectively evaluate CTCA in patients who underwent CTO PCI and correlate calcification characteristics with CTO PCI outcomes and tools utilised for calcium modification.


Clinical Trial Description

Cohort: All coronary CTO patients who underwent a PCI attempt and also underwent CTCA at our centre in the last 5 years. Method of identifying and consenting patients: Screening of our local database to identify suitable patients who fulfil the inclusion/exclusion criteria. These patients will be telephoned and the consent form and participant information sheet will be maile dot them along with a self addressed stamped envelope.On receipt of the consent form, we will countersign it and return a copy to the patient. Consented patients' images and reports of the CTCA and CTO PCI will be reviewed. Characteristics of calcification in the CTO on the CTCA will be evaluated including site, density and quantity of calcification. This will be correlated with CTO PCI outcomes of success and failure. Also this will be correlated with use of calcium modification tools for the CTO PCI. - Baseline and demographic as well as procedural data will be compared with CTO PCI outcomes and presence/characteristics of calcification. - Characteristics of calcification in the CTO assessed will include: site, density in Hounsfield units and quantity. - Site of calcification (proximal, body or distal) will be correlated with the CTO PCI outcome by chi square analysis. - Calcium density (in Hounsfield Units) on the CTCA will be correlated with successful versus failed CTO PCI by ROC curve analysis. - Quantity of calcification will be assessed as a percentage of the cross section of the CTO body (as <50%, 50-75% and 75-100%) and correlated with CTO PCI success by contingency analysis. - Use of calcium modification tools will be correlated with CTO PCI outcome (success or failure) and density of calcification on CTCA (ROC curve and ANOVA). - Categorical variables will be compared by the chi square or Fisher's test and continuous variables will be compared by the Mann Whitney U test. In addition, based on CTO PCI outcome of success or failure, patients will be compared for demographics and procedural variables. - Categorical variables will be presented as percentage and compared with the chi square or Fisher's test - Continuous variables will be presented as median (range) and compared with student's t-test or Mann Whitney test. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT06414551
Study type Observational
Source Sandwell & West Birmingham Hospitals NHS Trust
Contact Vinoda Sharma, FRCP
Phone +44(0)1215075841
Email vinodasharma@nhs.net
Status Not yet recruiting
Phase
Start date July 1, 2024
Completion date July 1, 2025

See also
  Status Clinical Trial Phase
Terminated NCT03959072 - Cardiac Cath Lab Staff Radiation Exposure
Completed NCT03475888 - Incidence of Ventricular Arrhythmias in Patients With Chronic Total Occlusion Recanalization N/A
Not yet recruiting NCT04917432 - Early and Midterm Outcomes of Intravascular Ultrasound (IVUS) Versus Non-IVUS Guidance in Complex Coronary Chronic Total Occlusion (CTO) Revascularization. N/A
Recruiting NCT04944615 - To Evaluate Whether IVUS-guided Drug-eluting Stent (DES) Implantation Leads to Better Clinical Outcomes Compared to Conventional Angiography in the Treatment of Chronic Complete Occlusion (CTO) Disease. N/A
Completed NCT01861860 - OPtimized Stenting Using Intravascular Ultrasound(IVUS) in Long lEsion: Rationale for Simplified criteriA N/A
Recruiting NCT05142215 - A Placebo-controlled Trial of Chronic Total Occlusion Percutaneous Coronary Intervention for the Relief of Stable Angina N/A
Active, not recruiting NCT05464147 - DYNAMX Bioadaptor ImplanTation for the trEatment of Complex Coronary Lesions N/A
Recruiting NCT04145167 - Observational Registry on Clinical Outcome After Diagnosis of Chronic Total Occlusions
Not yet recruiting NCT04965207 - EvaLuAtion On the cHaracteristics of the True/False lUmen and Its Prognostic Value for cOronary CTO Patients Just Before Stent Implantation
Active, not recruiting NCT05197361 - Microvascular Coronary Resistance and Absolute Coronary FLOW in Patients With Percutaneous Intervention of a Chronic Total Occlusion
Recruiting NCT05813704 - Coronary Crossing System in Patients With Coronary Chronic Total Occlusions N/A
Recruiting NCT03563417 - ISCHEMIA-CTO Trial - Revascularisation or Optimal Medical Therapy of CTO N/A
Completed NCT05377866 - Holo CTO Proctoring Study
Completed NCT01978860 - A Prospective, First in Man Study to Evaluate the Safety and Performance of the NovaCross™ Micro-catheter N/A
Withdrawn NCT02784418 - The SHINE-CTO Trial N/A
Completed NCT03988166 - Chronic Total Occlusion Percutaneous Coronary Intervention Study N/A
Completed NCT02477579 - A Prospective, Multi-Center, Pivotal Study to Evaluate the Safety and Effectiveness of the NovaCross™ Micro-catheter in Facilitating Crossing Chronic Total Occlusion (CTO) Coronary Lesions N/A
Completed NCT03209843 - Post-stenting Assessment of Reendothelialization With OFDI After CTO Procedure (PERFECTO) N/A
Completed NCT03947398 - The BLIMP Balloon in Coronary Interventions N/A
Active, not recruiting NCT04060615 - Properties of Myocardial Microcirculation in Patients With Different Pathomorphological Substrates, Before and After Recanalization of Coronary Artery CTO N/A